Fig. 2From: Cryptolepine inhibits hepatocellular carcinoma growth through inhibiting interleukin-6/STAT3 signallingCryptolepine differentially regulates signal transduction pathways in HepG2 cells. The cells were reversed transfected at 8 × 104 cells per well in the 96-well Cignal Finder 45-Pathway Reporter Array Plate. At 24 h post-transfection, the cells were treated with a fresh medium containing 5 μM cryptolepine for 24 h. Expression of the transcription factors was measured using the dual luciferase reporter gene assay and expressed in Log2 of fold change. Data are presented as means and standard deviations of three independent experiments, with each experiment conducted in duplicateBack to article page